Type	Name	Date
Indenture	Indenture, between Cubist Pharmaceuticals, Inc. and the Bank of New York Mellon Trust Company, N.A. (including the form of the 1.125% Convertible Senior Note due 2018)	09/10/2013
Indenture	Indenture, between Cubist Pharmaceuticals, Inc. and the Bank of New York Mellon Trust Company, N.A. (including the form of the 1.875% Convertible Senior Note due 2020)	09/10/2013

Type	Name	Date
By-Laws	Amended and Restated By-Laws of Cubist Pharmaceuticals, Inc	01/21/2015

Type	Name	Date
Merger agreement	Agreement and Plan of Merger, among Cubist Pharmaceuticals, Inc., FRD Acquisition Corporation and Adolor Corporation	10/24/2011